Snow Centre Special Seminar hosted by Professor Jason Tye-Din

Francisco Leon, MD, PhD

Founder and CEO, Tolerance Bio

Experimental Approaches to Preserve, Restore and Modulate Thymic Function for the Treatment and Prevention of Immune Diseases

 

Davis Auditorium

Join via SLIDO enter code #WEHIseminar

Including Q&A session

Francisco Leon, MD, PhD, is an immunologist and entrepreneur. He is the Founder and CEO of Tolerance Bio, a biotech focused on the preservation and regeneration of the thymus to prevent and treat immune diseases to extend healthspan.

Francisco career spans academia (NIH) and biopharma (BMS, MedImmune/AZ, Centocor/Janssen/JNJ, Celimmune/Amgen, Provention/Sanofi). Two of his co-founded companies were acquired by Pharma: Celimmune, focused on celiac disease, acquired by Amgen in 2017; and Provention Bio, focused on autoimmunity, acquired by Sanofi in 2023. He has served as co-founder, CEO, CMO, CSO and Board Director of several innovative immunology biotech companies, including active companies Paulex (diabetes), Praetorian (cavities/gingivitis vaccines), Avalor (osteoarthritis), Lapix (autoimmunity), VaxDyn (bacterial vaccines) and Glutenostics (celiac disease diagnostics).

He has co-authored over 100 peer-reviewed scientific articles and book chapters, and over 20 patents, and has led or participated in the development of 6 drugs which have reached the market, most recently teplizumab (TZIELD®) for the delay or prevention of the onset of clinical Type 1 Diabetes.

All welcome!